| Accession |
PRJCA014094 |
| Title |
ZS-01-308-Placebo-controlled Phase III trial evaluating the effects of recombinant Human Newland Green for injection on cardiac function in patients with chronic systolic heart failure |
| Relevance |
Medical |
| Data types |
clinical data
|
| Organisms |
Homo sapiens
|
| Description |
A multicenter, randomized, double-blind, placebo-parallel controlled trial evaluating the effect of recombinant human Newland Green for injection on cardiac function in patients with chronic systolic heart failure |
| Sample scope |
Homo sapiens |
| Release date |
2023-12-31 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Shanghai Zesheng Technology Development Co., LTD
|
|
NA
|
|
|
|
| Submitter |
Yan
Xiao
Qin (qinxiaoyan@zensun.com)
|
| Organization |
Shanghai Zesheng Technology Development Co., LTD., |
| Submission date |
2022-12-28 |
